Comments on “Anatomically distinct fibroblast subsets determine skin autoimmune patterns”

[1]  Yucheng Hu,et al.  Anatomically distinct fibroblast subsets determine skin autoimmune patterns , 2021, Nature.

[2]  Woan‐Ruoh Lee,et al.  Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention , 2021, Frontiers in Cell and Developmental Biology.

[3]  P. McDonel,et al.  scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function , 2021, Science Translational Medicine.

[4]  G. Kollias,et al.  Fibroblasts as immune regulators in infection, inflammation and cancer , 2021, Nature Reviews Immunology.

[5]  N. Hacohen,et al.  Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses , 2021, Science Translational Medicine.

[6]  Stephanie A. Santorico,et al.  The Genetic Basis of Vitiligo. , 2020, The Journal of investigative dermatology.

[7]  J. Rambert,et al.  Type-1 cytokines regulate matrix metalloprotease-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo. , 2020, JCI insight.

[8]  I. Katayama,et al.  GPNMB is expressed in human epidermal keratinocytes but disappears in the vitiligo lesional skin , 2020, Scientific Reports.

[9]  K. Essien,et al.  Vitiligo: Mechanisms of Pathogenesis and Treatment. , 2020, Annual review of immunology.

[10]  Lingyun Wu,et al.  The impact of NBUVB on microbial community profiling in the lesional skin of vitiligo subjects. , 2020, Microbial pathogenesis.

[11]  E. Fuchs,et al.  Epithelial cells: liaisons of immunity. , 2019, Current opinion in immunology.

[12]  F. Aubin,et al.  Vitiligo under anti-PD1 therapy is associated with increased survival in melanoma patients. , 2019, Journal of the American Academy of Dermatology.

[13]  P. Abbe,et al.  Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo , 2019, Nature Communications.

[14]  J. Richmond,et al.  Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo. , 2019, The Journal of investigative dermatology.

[15]  J. Richmond,et al.  Mouse Model for Human Vitiligo , 2018, Current protocols in immunology.

[16]  Wei Xie,et al.  Hoxc-Dependent Mesenchymal Niche Heterogeneity Drives Regional Hair Follicle Regeneration. , 2018, Cell stem cell.

[17]  F. Watt,et al.  Skin Cell Heterogeneity in Development, Wound Healing, and Cancer , 2018, Trends in cell biology.

[18]  Xin Li,et al.  PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin , 2018, Scientific Reports.

[19]  W. Janssen,et al.  Promoter Specificity and Efficacy in Conditional and Inducible Transgenic Targeting of Lung Macrophages , 2017, Front. Immunol..

[20]  K. Ezzedine,et al.  Current and emerging treatments for vitiligo. , 2017, Journal of the American Academy of Dermatology.

[21]  G. Kollias,et al.  Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions , 2017, Nature Communications.

[22]  L. Folkersen,et al.  CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin , 2017, Immunity.

[23]  A. Luster,et al.  Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease. , 2017, The Journal of investigative dermatology.

[24]  D. Fisher,et al.  Metastatic melanoma and immunotherapy. , 2016, Clinical immunology.

[25]  D. Didona,et al.  Vitiligo: Pathogenesis, clinical variants and treatment approaches. , 2016, Autoimmunity reviews.

[26]  Monzoorul Haque Mohammed,et al.  Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects , 2016, Scientific Reports.

[27]  J. Soria,et al.  Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab. , 2016, JAMA dermatology.

[28]  Lei Wang,et al.  Organ-Level Quorum Sensing Directs Regeneration in Hair Stem Cell Populations , 2015, Cell.

[29]  Ming Li,et al.  Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo. , 2015, Acta dermato-venereologica.

[30]  D. Sugiyama,et al.  Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals , 2014, Science.

[31]  T. Lotti,et al.  The role of neuropeptides in the control of regional immunity. , 2014, Clinics in dermatology.

[32]  Liangjun Lu,et al.  Interferon-γ Induces Senescence in Normal Human Melanocytes , 2014, PloS one.

[33]  Peisheng Zhang,et al.  Autoimmune Vitiligo Does Not Require the Ongoing Priming of Naive CD8 T Cells for Disease Progression or Associated Protection against Melanoma , 2014, The Journal of Immunology.

[34]  C. Hunter,et al.  CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo , 2014, Science Translational Medicine.

[35]  M. Nishimura,et al.  A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo , 2013, The Journal of investigative dermatology.

[36]  M. Nishimura,et al.  Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo , 2013, Science Translational Medicine.

[37]  R. Gallo,et al.  Innate immune defense system of the skin. , 2013, Veterinary dermatology.

[38]  E. Fuchs,et al.  An RNA interference screen uncovers a new molecule in stem cell self-renewal and long-term regeneration , 2012, Nature.

[39]  E. Wherry,et al.  A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T cell accumulation in the skin , 2011, The Journal of investigative dermatology.

[40]  Meaghan Daly,et al.  Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. , 2011, Journal of the American Academy of Dermatology.

[41]  A. Luster,et al.  CXCR3 in T cell function. , 2011, Experimental cell research.

[42]  L. Liaw,et al.  The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells , 2010, Genesis.

[43]  Andrew V. Nguyen,et al.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. , 2010, The American journal of pathology.

[44]  V. Engelhard,et al.  Mechanisms of Spatial and Temporal Development of Autoimmune Vitiligo in Tyrosinase-Specific TCR Transgenic Mice , 2010, The Journal of Immunology.

[45]  C. Melief,et al.  Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. , 2009, The Journal of investigative dermatology.

[46]  M. Namazi,et al.  Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected? , 2007, Pigment cell research.

[47]  Arthur D Lander,et al.  Morpheus Unbound: Reimagining the Morphogen Gradient , 2007, Cell.

[48]  Howard Y. Chang,et al.  Anatomic Demarcation by Positional Variation in Fibroblast Gene Expression Programs , 2006, PLoS genetics.

[49]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[50]  R. Paus,et al.  The hair follicle and immune privilege. , 2003, The journal of investigative dermatology. Symposium proceedings.

[51]  F. Benvenuto,et al.  Dominant TCR-α Requirements for a Self Antigen Recognition in Humans , 2002, The Journal of Immunology.

[52]  David Botstein,et al.  Diversity, topographic differentiation, and positional memory in human fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Bosq,et al.  Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo. , 2001, The Journal of investigative dermatology.

[54]  A. Necker,et al.  Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. , 2001, The Journal of investigative dermatology.

[55]  H. Rammensee,et al.  HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. , 2001, The Journal of investigative dermatology.

[56]  A. Taïeb,et al.  Intrinsic and extrinsic pathomechanisms in vitiligo. , 2000, Pigment cell research.

[57]  G. Ogg,et al.  High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo , 1998, The Journal of experimental medicine.

[58]  W. Westerhof,et al.  Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. , 1996, The American journal of pathology.

[59]  E. Farber,et al.  Stress, symmetry, and psoriasis: possible role of neuropeptides. , 1986, Journal of the American Academy of Dermatology.

[60]  K M Halprin,et al.  EPIDERMAL “TURNOVER TIME”—A RE‐EXAMINATION , 1972, The British journal of dermatology.

[61]  G. Rudy.  Lichen planus. , 1966, The McGill dental review.